If you want to get inside of your pet's head, the tech hasn't arrived yet, but one company hopes to have it trending in the right direction.
Los Angeles-based FluentPet has developed a series of tiles it claims help four-legged companions communicate with their humans. Through training, they can learn to associate various tiles with words they've learned over time and then use their paws to press them.
The tech has been a hit on platforms like TikTok, where tons of "talking dog" videos have gone viral.
There are a wide range of options to select from when it comes to purchasing the tech. Test kits start out around $35 with the most expensive option, They Can Talk Kit, being priced around $230.
The company also recently launched FluentPet Connect, which integrates the tile button system into an app. This helps keep pet owners connected to their pets at all times. If a person isn't home, their pet could send an alert, similar to a text message.
The system is available for an additional $69.99 but is compatible with tiles that have already hit the market.
However, devices like FluentPet and the studies that have been done with their subjects do face skepticism from scientists. Clive Wynne, the founding director of the Canine Science Collaboratory at Arizona State University, explained that rather than language comprehension, the dogs are being conditioned.
“This is one of the most basic forms of learning in the animal kingdom," Wynne told the Washington Post. "The dog forms an association between an action and an outcome that it desires.”
Disney+ miss on new subscribers in Q3 and the growing momentum for moviegoers returning to brick-and-mortar theaters has brought the streaming business into question. Seth Schachner, managing director at Strat Americas, joined Cheddar to discuss the state of streaming and the growing number of options consumers have. "Streaming is for sure here to stay and I think more robust than ever," he said. "The real thing that's happening, not just to Hollywood but to lots of verticals from music to sports, is just that there's tons and tons of consumer choice."
Peter Weber, author and star of ABC's The Bachelor, joined Cheddar to talk about his new children's book, "The Adventures of Pilot Pete," scheduled for release on Nov. 23. Weber, a real commercial pilot, said that while fellow Bachelor Nation contestants tend to write books following their experience on the small screen, one of the reasons he opted to write a children's book instead was the prospect of the longevity it could provide.
Dr. Wendy Osefo, Entrepreneur, Professor & Cast Member of Bravo's 'Real Housewives of Potomac', joins 'Your Future Home' to discuss her popular new Onyi Home Essentials line and how ideas of family and legacy helped shape it.
David Girouard, CEO of Upstart, an artificial intelligence lending platform, joined Cheddar to discuss Q3 earnings, noting growth in revenue and profits as more banks, credit unions, and car dealerships use Upstart tech. He also reflected on how his fintech company is working to help people with low credit or no credit secure access to credit and loans.
With the shortage of shipping containers and truck drivers, the global supply chain is taking a beating just ahead of the holiday season. As retailers gear up to meet higher demand, DHL Express is adding capacity, both in infrastructure and aviation. Greg Hewitt, U.S. CEO at DHL Express, joined Cheddar's Opening Bell to provide some additional details on the ramped-up investments.
Electric vehicle startup Rivian is disrupting the auto industry following its record-breaking public debut on Wednesday taking it to a higher market value than legacy automakers Ford and General Motors. Thomas Speidel, CEO at fast battery-charging firm ADS-Tech Energy, joined Cheddar to talk about what the IPO means for the broader development of electric vehicles in the U.S. He also talked about the pressure Ford faces after its gas-powered F-150 had been the best-selling vehicle in the U.S. for nearly 45 years.
Moderna is defending its COVID-19 vaccine after a study found an increase in reports of myocarditis, which is an inflammation of the heart, in males ages 12 to 29 — about 13.3 cases in every 100,000 subjects. The pharmaceutical giant said the benefits of the vaccine outweigh the risk of the possible negative side effect.
